Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1226695

Cover Image

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1226695

Contrast Media Injection Sets Market: Current Analysis and Forecast (2022-2028)

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3999
PDF (Site License - Up to 5 Users)
USD 5499
PDF (Global License)
USD 6999

Add to Cart

The contrast media injection sets market is expected to register a CAGR of approx. 5% over the period of 2022-2028. Contrast media administration sets, or injection sets are made to regulate the number of contrast agents that are actually supplied to an administration system (such as an injector) in order to prevent waste and regulate the total amount of contrast agents used for a single procedure. When performing various imaging tests like computed tomography (CT), magnetic resonance imaging (MRI), radiography, and occasionally ultrasound imaging, contrast media are used to increase the contrast of bodily fluids for better imaging. With the aid of contrast media, blood vessels can be seen, allowing for the examination of the spine, kidneys, and internal organs of the brain. Contrast media aids in the differentiation of different body parts with similar compositions, and thus, contrast media. The growing demand for contrast media injection sets can be attributed to the increasing prevalence of cancer across the globe. For instance, according to the World Health Organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Owing to the glaring statistics the rising prevalence of cancer leads to higher demand for contrast media injection which boosts the demand for contrast media injection sets across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the contrast media injection sets market is anticipated to grow on account of the increasing number of diagnostic procedures. In addition, increasing usage of nuclear imaging tests for the diagnosis of various conditions related to the heart, lungs, bones, brain, and other systems drives the market growth. However, some of the restraints in the market including the high cost of injection sets and lack of trained professionals are impeding the growth of this market all over the world.

Based on the product, the contrast media injection sets market is segmented into contrast media injection sets with a bore vented tubing, contrast media injection sets with a vented bifurcated standard bore, contrast media injection sets with a vented pressurized spike, and others. The contrast media injection sets with a bore vented tubing segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Professionals frequently use these products because they are simple to use and more widely available than other product categories.

Based on the end-user, the market is fragmented into hospitals, cancer research institutes, diagnostic imaging centers, and others. The diagnostic imaging centers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Increased procedure volume, combined with patient convenience, and a lack of imaging modalities in small and medium-sized hospitals are boosting segment growth. In order to improve ease of use and create products that can help control the waste of contrast agents, manufacturers of contrast media injection sets are concentrating on creating more innovative sets.

For a better understanding of the market adoption of the contrast media injection sets, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the contrast media injection sets industry owing to increased nuclear imaging procedures and the availability of high-end products. Moreover, the presence of well-established healthcare facilities, growing advanced technologies, as well as rising healthcare spending boost the market growth in this region.

Some of the major players operating in Bayer AG; ulrich GmbH & Co. KG; Medtron AG; ICU Medical, Inc; B. Braun SE; Apollo Rt Co. Ltd; Nemoto Kyorindo Co. Ltd; Guerbet Group; GE Healthcare; Shenzhen Anke High-tech Co. Ltd among others. Several M&A's along with partnerships have been undertaken.

Product Code: UMME211581

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Contrast Media Injection Sets Market
  • 2.2. Research Methodology of the Contrast Media Injection Sets Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CONTRAST MEDIA INJECTION SETS MARKET

6 GLOBAL CONTRAST MEDIA INJECTION SETS MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Contrast Media Injection Sets with a Bore Vented Tubing
  • 7.2. Contrast Media Injection Sets with a Vented Bifurcated Standard Bore
  • 7.3. Contrast Media Injection Sets with a Vented Pressurized Spike
  • 7.4. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Cancer Research Institutes
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Others

9 MARKET INSIGHTS BY REGION

  • 9.1 NORTH AMERICA CONTRAST MEDIA INJECTION SETS MARKET
    • 9.1.1 U.S.
    • 9.1.2 Canada
    • 9.1.3 Rest of North America
  • 9.2 EUROPE CONTRAST MEDIA INJECTION SETS MARKET
    • 9.2.1 Germany
    • 9.2.2 France
    • 9.2.3 U.K.
    • 9.2.4 Spain
    • 9.2.5 Italy
    • 9.2.6 Rest of Europe
  • 9.3 ASIA PACIFIC CONTRAST MEDIA INJECTION SETS MARKET
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4. Australia
    • 9.3.4 Rest of Asia Pacific
  • 9.4 REST OF WORLD CONTRAST MEDIA INJECTION SETS MARKET

10 CONTRAST MEDIA INJECTION SETS MARKET DYNAMICS

  • 10.1 Market Drivers
  • 10.2 Market Challenges
  • 10.3 Impact Analysis

11 CONTRAST MEDIA INJECTION SETS MARKET OPPORTUNITIES

12 CONTRAST MEDIA INJECTION SETS MARKET TRENDS & INSIGHTS

13 DEMAND AND SUPPLY SIDE ANALYSIS

  • 13.1 Demand Side Analysis
  • 13.2 Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

  • 18.1. Bayer AG
  • 18.2. ulrich GmbH & Co. KG
  • 18.3. Medtron AG
  • 18.4. ICU Medical, Inc
  • 18.5. B. Braun SE
  • 18.6. Apollo Rt Co. Ltd
  • 18.7. Nemoto Kyorindo Co. Ltd
  • 18.8. Guerbet Group
  • 18.9. GE Healthcare
  • 18.10. Shenzhen Anke High-tech Co. Ltd

19 DISCLAIMER

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!